Oil has become a favorite mode of administration for many medical users of cannabis and cannabinoids for multiple reasons. First of all, concentrated extracts allow the consumption of a large dose of cannabinoids in an easily ingestible form. With CBD oil, there is no risk of intoxication (getting high) , so much larger doses can be consumed than would be possible for THC-rich products. Many users who prefer the holistic approach of using herbal cannabis worry about the stigma associated with the typical smell caused by smoking or vaporizing it. Cannabis oil has no smell that may identify a consumer as a cannabis user, and it can be used discretely even in a social setting, e.g., at work or around family. Moreover, it can be efficiently dosed simply by counting the number of drops consumed. These same benefits of using a concentrated extract were identified in a large survey among medicinal cannabis users published in 2013 , perhaps as an early indicator of the emergence of cannabis oils as a preferred method of ingestion. Currently, the market is developing further towards more sophisticated and patentable products, including oral capsules, liposomal products, skin creams, and chewing gums containing CBD.
Almost overnight, CBD oils have become an interesting combination of popular holistic medicine, miracle cure, and a natural answer to the synthetic drugs dominating modern medicine. With CBD, patients receive the promise of being in control of their own ailments, and no longer feeling at the mercy of their treating physicians. This has turned out to be a particularly powerful message. Many patients use CBD oils freely for ailments both confirmed and self-diagnosed, and the rapid innovations with CBD products have actually been quite impressive. But while new CBD products keep entering the market virtually unchecked, effective regulatory control of these products has stayed far behind. As a result, unknown risks about long-term effects remain unaddressed, especially in vulnerable groups such as children, the elderly, and the chronically or terminally ill. It should be noted that this discussion goes well beyond CBD only, as new products containing additional cannabinoids like CBG, THCV, and acidic cannabinoids are following closely behind. We know even less about these compounds than about CBD, and very limited human safety data are available.
Due to its wide variety of medical benefits, CBD is used to treat a number of common conditions, including chronic pain, inflammation, seizures, insomnia, spasms, multiple sclerosis, and mental disorders such as anxiety and depression. As a topical agent, CBD oil can be directly applied to certain areas of the body as an effective means of relieving pain and soreness, reducing inflammation, and soothing inflammatory skin conditions such as psoriasis, dermatitis, and eczema.
Various studies done on CBD oils and other cannabis products around the world have come to similar conclusions about incorrect label information [24, 53, 54] and the presence of contaminants [54-57]. In the absence of a clear legal status for CBD, or agreement on common safety and quality standards, it may not be surprising that current CBD products leave something to be desired. The time has come for regulators to give CBD the attention it deserves in order to ensure that affordable, safe, and reliable CBD products are available to those who depend on them.
In the United States, the CBD drug Epidiolex has been approved by the Food and Drug Administration for treatment of two epilepsy disorders. The U.S. Drug Enforcement Administration has assigned Epidiolex a Schedule V classification while non-Epidiolex CBD remains a Schedule I drug prohibited for any use. CBD is not scheduled under any United Nations drug control treaties, and in 2018 the World Health Organization recommended that it remain unscheduled.
Flower Power, which sells CBD-infused coffee to cafes like Caffeine Underground in New York City, puts 5 mg of CBD in each serving of coffee. The company, like many involved in the sale of CBD, is extremely careful about what it says regarding CBD’s effects for fear of FDA intervention. The standard language for CBD packaging and website documentation is similar to that of many supplements (think: milk thistle, echinacea, elderberry, turmeric) and is some variation on: “These statements have not been evaluated by the Food and Drug Administration. These products are not intended to diagnose, treat, cure, or prevent any disease or ailment.”
So far, by far the best medicinal relief I have found for my symptoms is a particular strain of cannabis flower called Harlequin — it contains an almost 3:1 ratio of CBD:THC, which is extremely rare and unique in the cannabis world. There are multiple studies you can find online showing the SYNERGISTIC effects of CBD combined with THC. When they are used together, they are much more medicinally effective than either one is on their own. Most cannabis strains today have zero CBD because growers realized everyone just loves their THC, but the Harlequin strain is a god send.
Kent, My mother has suffered from severe migraines since she was a child. Six weeks ago, she received the hemp oil tincture (I do not know what dosage). She does not take it daily. She rubs a drop or two on her temples at the start of a migraine. The drops worked more effectively for her than her medication did, and now that is all she uses. Hope this helps.
As CBD oil is non-psychoactive, applying it to the skin does not create mind-altering effects in the same manner that THC ingestion does.3 Therefore, the use of CBD in topical form is a useful alternative for those who wish to avoid the psychoactive effects of THC and those who would like options besides the over-the-counter steroid-based creams typically used for arthritis, joint pain, and similar ailments. This is especially true for aging users, parents, or adults who are concerned about practical matters (like failing drug tests, for example).
THC, an intoxicating and illegal substance, is responsible for causing marijuana users to get “high.” Unlike THC, CBD is non-psychoactive because it does not act on the same pathways as THC. Thus, it is impossible to get “high” by smoking or ingesting CBD or CBD oil extracted from industrial hemp plants, as they only have minuscule traces of THC (<0.3%).
As it turns out, CBD (short for cannabidiol) is a phenomenal natural therapy for literally dozens and dozens of different ailments. General pain relief is probably the single most common reason that people take CBD, but it’s also proven to be extremely effective for psychological conditions like anxiety and depression, as well as for things like chronic seizures/epilepsy, diabetes, migraines, neurodegenerative disease (multiple sclerosis, fibromyalgia), digestive issues, and even menstrual cramps.
It may have something to do with the fact that THC stimulates that CB1 receptor a lot, in turn triggering the psychoactive effects of marijuana like disturbed sensory perception, impaired motor skills, and anxiety. Conversely, CBD stimulates CB1 very lightly, causing some effects that seem downright opposed to those of THC including relief from anxiety, stress, and hyper-excitability.
Cannabidiol (CBD), a non-psychoactive segment of the marijuana plant, has created huge enthusiasm among researchers and physicians. CBD Oil applies its remedial effect on an atomic level is as yet being sorted out. Cannabidiol is a pleiotropic sedate in that it produces numerous impacts through various atomic pathways. CBD Oil acts through different receptor-free channels and by official with various non-cannabinoid receptors and particle channels.
Our Editor’s Pick is the tincture from CBDistillery. This tincture is available in five strengths ranging from 250mg to 5,000mg, which accommodates a wide range of THC preferences, as well as 15 and 30 milliliter containers. The tincture has a price-point that is slightly below average, making it a good option for value seekers. The tincture, which is non-flavored, routinely undergoes third-party testing to ensure safety and high quality; the testing results are available on CBDistillery’s product pages.